Why IBM, EQT, Calithera Biosciences, Amazon, and Facebook Are Trending

Page 2 of 2

Calithera Biosciences Inc (NASDAQ:CALA) are 21% in the red after Robyn Karnauskas of Citi initiated a ‘Sell’ rating and $1 price target on the stock. Karnauskas doesn’t see any catalysts in the near term, and thinks it could take a while before meaningful data trickles out from the company’s studies on cancer metabolism. Eight funds from our database had bullish positions (accounting for 19.00% of the float in aggregate) in Calithera Biosciences Inc (NASDAQ:CALA) at the end of the second quarter.

Follow Calithera Biosciences Inc. (NASDAQ:CALA)

Two technology giants are in the spotlight after noted investor Andrew Left of Citron said that he was short Facebook Inc (NASDAQ:FB) and long Amazon.com, Inc. (NASDAQ:AMZN) as a pair trade. Given that the market caps of the two are similar, Left believes Amazon will outperform because he sees much more value in the e-commerce giant in the long term. Left also added that it “will be interesting to see how FB matures as the “sharing” phenomenon slows down”. According to our data, the smart money still loves both tech giants as 145 funds held shares of  Amazon.com, Inc. (NASDAQ:AMZN) and 148 were long Facebook Inc (NASDAQ:FB) at the end of June.

Follow Amazon Com Inc (NASDAQ:AMZN)

Follow Meta Platforms Inc. (NASDAQ:META)

Disclosure: none

Page 2 of 2